Samantha Sault

Nov 21, 2024 | bio.news | Samantha Sault |Camila Zavala

On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community advocates at Howard University in Washington, D.C. Organized in collaboration with Howard University and the Diversity Convergence Project, the summit addressed one of the most pressing issues in clinical research: the lack of diversity and inclusion in clinical trials.

Mar 29, 2024 | bio.news | David Thomas |Samantha Sault |CFA David Thomas

A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels not seen since 2017. Everything from venture capital to licensing was trending down significantly, and we were coming off the heels of the newly passed Inflation Reduction Act (IRA). It was hard to find positive signals to present at events such as BIO-Europe. But things have changed heading into 2024.

Mar 5, 2024 | bio.news | Samantha Sault

The Biotechnology Innovation Organization (BIO) 2024 CEO and Investor Conference (a.k.a. #BIOCEO24) took place February 26-27 in New York. The annual event brought together more than 1,000 attendees for a week of insightful panel discussions, networking, and BIO One-on-One Partnering™ to drive tomorrow’s biotech innovations.

Mar 1, 2024 | bio.news | Samantha Sault

On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome effort to gather more information and perspective on what patients and families are facing, and there’s no doubt that the stories that will be shared will be illuminating. In the spirit of “listening,” here are five realities that we hope come through loud and clear on Monday:1. Patients must come first.

Nov 2, 2023 | bio.news | Samantha Sault

Remarks from Dr. Ted W. Love, Chairman of the Biotechnology Innovation Organization (BIO) and former President and CEO of Global Blood Therapeutics, as prepared for delivery Georgia Bio’s Life Sciences Summit on November 1, 2023:Almost ten years ago, when our college-aged daughter Alex lived at home, I had a difficult time convincing her that our industry was a force for good.